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A previous analysis of the survival of endstage renal disease
(ESRD) patients stressed that survival on a second ESRD
treatment modality, such as home dialysis or transplantation,
must consider survival experience on the first treatment modal-
ity, which commonly is center dialysis [1]. That study found
differences in survival between center dialysis patients and
patients transplanted with kidneys from related donors for
patients between 15 and 44 years of age, but not for older
patients between 45 and 60 years of age. Furthermore, in
comparing the survival of cadaver transplant patients to that of
center dialysis patients, the relative risk of death for all ages
combined was slightly less than one, yet for each of the three
age groups considered the relative risk of death was greater
than one [11. These findings strongly suggested that valid
analyses of such differences in outcomes must adjust for the age
of patients. This study does so by re-analyzing the data reported
by Weller et al [I] with an improved statistical method referred
to in the previous report [1] and which has been used by
Hutchinson, Thomas, and MacGibbon [2]. It, again, looks at
survival on the second treatment modality, home dialysis or
transplantation, while evaluating survival experience on the
first treatment modality, center dialysis. This new analysis
provides additional insights into the effect of age of ESRD
patients on treatment differences.
Methods. All 36 ESRD dialysis facilities and 12 transplanta-
tion centers in the State of Michigan regularly submitted patient
data to the Michigan Kidney Registry (MKR) during the 5-year
period, January 1974 through December 1978. In this time
period a total of 2,493 ESRD patients in the State of Michigan
started on dialysis (hemodialysis or peritoneal dialysis) in a
center and/or, initially or subsequently, some used home dialy-
sis or received a renal transplant. The longest follow-up time for
any patient was 6 years from the start of center hemodialysis.
Of the 2,493 patients beginning treatment for ESRD during this
interval, 70 patients were excluded from the study because of
imprecise starting dates of initial center dialysis. In addition, 27
patients who had no dialysis prior to the first transplantation
arbitrarily were excluded, From the remaining group of 2,396
center dialysis patients, 261 individuals were trained for and
conducted dialysis at home, 173 were transplanted with kidneys
from related donors, and 402 received kidneys from cadaver
donors.
In this study, patients receiving home dialysis or renal
transplantation are considered to remain in that treatment group
until death or withdrawal although they subsequently returned
to center dialysis. The age used for a patient is the age when
treatment began for ESRD. The average age was 47.0 years (SD
= 16.5 years). Fifty-eight percent of the ESRD patients were
male; 64% were white; and 34% were black.
The method for statistical analysis used here has been applied
previously in the analysis of survival for ESRD patients [21.
Specifically, the method of Crowley and Hu [31 is a general
method for life-table analysis that allows for changing therapies
through time-dependent covariates using the Cox model [4] and
simultaneously adjusts for patient characteristics. The neces-
sary computer program for applying this procedure is available
in the Biomedical Computer Program package—BMDP2L [5].
The Cox proportional hazards regression model is formulated
in terms of the effect of covariates upon death (hazard) rates.
Suppose h(t;z) is the hazard rate for an individual with covari-
ate vector z. The proportional hazards model is given by
h(t;z) = h0(t)exp('z)
where is the vector of unknown regression coefficients and
h0(t) is an unknown hazard function for an individual with
covariate vector z = 0. Estimates of the regression coeffi-
cients and their asymptotic standard errors and correlations can
be calculated. Models which include covariates expressible as
functions of time are necessary when a patient's outcome may
change as a result of some event during the course of treatment.
In the model used for this analysis, a time-dependent covariate
was utilized to indicate the time that a change in treatment
status was made. Age was included as a time-independent
covariate. An additional time-dependent covariate was the
interaction between age and treatment group. Age was defined
as the deviation of the individual patient's age from the mean
age of all of the patients included in a given analysis.
Results. Table 1 summarizes this current analysis of survival
experience based on the method proposed by Crowley and Hu
[3]. These results are presented graphically in Figure 1. Figure 1
shows that the risk of death for a patient on home dialysis is less
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Table 1. Cornparison of survival of home dialysis, related transplant, and cadaver transplant patients to center dialysis patients
Treatment
modality Variable Coefficient s Coefficient/SE
Correlation matrix
Age Trt Age x Trt
Home dialysis Age (51.31 15.31)a
Treatment
Age x Treatment
0.0121
—0.4615
0.0068
0.0026
0.1176
0.0087
4.72
—3.92
0.78
1.000
0.054
—0.293
1.000
0.216 1.000
Related transplant Age (49.97 16.50)
Treatment
Age x Treatment
0.0143
—0.6036
0.0349
0.0025
0.3092
0.0155
5.77
—1.95
2.25
1.000
0.033
—0.159
1.000
0.689 1.000
Cadaver transplant Age (48.81 16.24)
Treatment
Age x Treatment
0.0205
0.3390
0.0120
0.0025
0.1278
0.0079
8.22
2.65
1.53
1.000
0.101
—0.317
1.000
0.531 1.000
a Mean SD.
than the risk of death for a patient on center dialysis at the same
age for all ages between 20 and 60. These ages were selected
since few patients less than 20 years of age were on center
dialysis or home dialysis and few patients greater than 60 years
of age received a cadaver or related transplant. Table 1 indi-
cates that this relative advantage of home dialysis is statistically
significant (P < 0.01) at all ages between 20 and 60. (An
example of this calculation of statistical significance based on
the data in Table 1 is provided in the Appendix.) Figure 1
suggests that the relative advantage of home dialysis compared
to center dialysis decreases with advancing age. However,
Table 1 shows that this interaction of treatment effect with age
is not statistically significant (z = 0.78). The risk of death for a
patient receiving a cadaver transplant exceeds the risk of death
for a patient on center dialysis at the same age for all ages
greater than 21. This relative disadvantage of cadaver trans-
plantation is not statistically significant for all ages between 20
and 60. Although Figure 1 suggests that the relative disadvan-
tage of cadaver transplantation compared to center dialysis
increases with advancing age, this interactive effect is not
statistically significant (Table 1, z = 1.53). Finally, the risk of
death for a patient receiving a related transplant is less than the
risk of death for a patient on center dialysis at the same age for
all ages considered. However, the effect of related transpianta-
tion compared to center dialysis varies depending on the age of
the patient. For patients aged 20, there is a significant difference
in the risk of death for related transplantation compared to
center dialysis. For patients aged 60, there is no significant
difference in the risk of death for related transplantation com-
pared to center dialysis. This interactive effect is significant (z
= 2.25, P 0.02, Table 1).
Discussion. This analysis of survival of home dialysis pa-
tients compared to that of center dialysis patients yields results
that are consistent with the earlier results [1] except for the
younger 15 to 29-year-old group. It suggests that the relative
80 advantage of home dialysis exists even for this younger age
group. The current analysis of survival of cadaver transplanta-
tion patients compared to that of center dialysis patients agrees
with the earlier results in that the relative disadvantage of
cadaver transplantation again is noted. Moreover, this new
analysis of related transplantation compared to center dialysis
gives results quite similar to those obtained earlier and confirms
the suggestion in the previous analysis of a treatment-by-age
interaction [1].
This current analysis using the method of Crowley and Hu [3]
is a generalization of the earlier report [1] based on the method
of Mantel and Byar [6]. An advantage of the present analysis is
that it allows for simultaneous adjustment of patient character-
istics and prior therapy without the problem of small samples
that can result from multiple subgroup analyses such as were
present in the earlier analysis. In the present analysis age is
included in the statistical model as a continuous variable, and,
thus, allows for more precise adjustment for that covariate.
This new analysis, therefore, provides a direct test for treat-
ment-by-age interaction. It is not appropriate to test for such
treatment-by-age interaction by making two separate tests for
treatment effects (say, at two different ages) and observing if
one test yields "P < 0.05" and the other test yields "P > 0.05."
A disadvantage of the current analysis is that the age effects are
assumed to be linear (on a logarithmic scale).
It should be emphasized that, for a valid analysis of treatment
differences in ESRD, all of the factors which relate to patient
selection for the various treatment modalities should be consid-
ered. Bias introduced by the selection process may be a major
determinant of the rate of survival of ESRD patients on a
treatment modality in addition to the effect of the treatment
itself [7]. Hence, we agree with Knapp [8] that the ideal
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Fig. 1. The relative risk of death of patients treated by home dialysis(a), related transplantation (S), and cadaver transplantation () as
compared to center dialysis (0) at any given patient age.
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comparison of treatment modalities is a prospective random-
ized trial of treatments with no change in management. Howev-
er, such studies may be difficult to implement [6]. Therefore,
detailed analyses of carefully collected comprehensive data
may be of value. Age, duration of diabetes mellitus, and
existence of left-sided heart failure have been suggested as
important covariates by Hutchinson, Thomas, and MacGibbon
[2]. Further analyses are indicative of comprehensive ESRD
data bases which consider other covariates using the method-
ology presented here to more adequately evaluate the effects of
selection biases on treatment outcome differences.
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Appendix
From the information presented in Table 1, one can statisti-
cally compare the survival experience of patients on a given
treatment modality to that of patients on center dialysis at the
same age. For example, the hazard rate for a 20-year-old patient
receiving home dialysis is:
h0(t)exp[0.0121(20 — 51.31) — 0.4615(1) + 0.0068(1)
(20 — 51.31)]
while the hazard rate for a 20-year-old patient receiving center
dialysis is:
h0(t)exp[0.0121(20 — 51.31) — 0.4615(0) + 0.0068(0)
(20 — 51.31)]
Hence, the ratio of the two hazard rates is:
exp[—0.4615 + 0.0068(—31.31)] = exp(—0.6744) = 0.51 (3)
To test if this ratio is different from one is equivalent to testing if
the estimated coefficient for treatment minus 31.31 times the
estimated coefficient for the interaction of age and treatment is
significantly different from zero in this model. By reference to
the standard errors and correlations presented in Table 1, it is
noted that the estimated variance of this linear combination of
estimated coefficients is:
(0.1176)2 + 2(—31.31)0.216(0.11767)(0.0087) +
(_31.31)2(0.0087)2 = (0.280)2 = 0.0784 (4)
Hence, the significance of the ratio of the two hazard rates is
determined by the following z statistic:
—0.6744z =
0.280
=
—2.41 (5)
By reference to a table of the standard normal distribution, it is
noted that this statistic is significant at P < 0.01.
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